Get started
Medpace Holdings, Inc.Medpace Holdings, Inc.Medpace Holdings, Inc.

Medpace Holdings, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

MEDP chart


Full chart

MEDP upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪10.42 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
29.34
Basic EPS (TTM)
11.83 USD
Net income (FY)
‪282.62 M‬ USD
Revenue (FY)
‪1.89 B‬ USD
Shares float
‪25.49 M‬
Beta (1Y)
1.71

Employees


Employees (FY)
‪5.9 K‬
Change (1Y)
+700 +13.46%
Revenue / Employee (1Y)
‪319.63 K‬ USD
Net income / Employee (1Y)
‪47.90 K‬ USD

About Medpace Holdings, Inc.


Sector
Commercial Services
Industry
Miscellaneous Commercial Services
CEO
August James Troendle
Website
medpace.com
Headquarters
Cincinnati
Founded
1992
FIGI
BBG0065B7K59
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

MEDP news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MEDP is 337.28 USD — it has increased by 0.64% in the past 24 hours. Watch Medpace Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Medpace Holdings, Inc. stocks are traded under the ticker MEDP.
MEDP stock has fallen by −3.11% compared to the previous week, the month change is a 7.54% rise, over the last year Medpace Holdings, Inc. has showed a 10.18% increase.
We've gathered analysts' opinions on Medpace Holdings, Inc. future price: according to them, MEDP price has a max estimate of 400.00 USD and a min estimate of 305.00 USD. Watch MEDP chart and read a more detailed Medpace Holdings, Inc. stock forecast: see what analysts think of Medpace Holdings, Inc. and suggest that you do with its stocks.
MEDP reached its all-time high on Jul 17, 2024 with the price of 459.77 USD, and its all-time low was 21.76 USD and was reached on May 3, 2017. View more price dynamics on MEDP chart.
See other stocks reaching their highest and lowest prices.
MEDP stock is 2.54% volatile and has beta coefficient of 1.71. Track Medpace Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is Medpace Holdings, Inc. there?
Today Medpace Holdings, Inc. has the market capitalization of ‪10.48 B‬, it has increased by 2.04% over the last week.
Yes, you can track Medpace Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
Medpace Holdings, Inc. is going to release the next earnings report on Feb 17, 2025. Keep track of upcoming events with our Earnings Calendar.
MEDP earnings for the last quarter are 3.01 USD per share, whereas the estimation was 2.77 USD resulting in a 8.64% surprise. The estimated earnings for the next quarter are 2.94 USD per share. See more details about Medpace Holdings, Inc. earnings.
Medpace Holdings, Inc. revenue for the last quarter amounts to ‪533.32 M‬ USD, despite the estimated figure of ‪540.99 M‬ USD. In the next quarter, revenue is expected to reach ‪534.86 M‬ USD.
MEDP net income for the last quarter is ‪96.43 M‬ USD, while the quarter before that showed ‪88.35 M‬ USD of net income which accounts for 9.14% change. Track more Medpace Holdings, Inc. financial stats to get the full picture.
No, MEDP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has ‪5.90 K‬ employees. See our rating of the largest employees — is Medpace Holdings, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Medpace Holdings, Inc. EBITDA is ‪437.53 M‬ USD, and current EBITDA margin is 19.26%. See more stats in Medpace Holdings, Inc. financial statements.
Like other stocks, MEDP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Medpace Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Medpace Holdings, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Medpace Holdings, Inc. stock shows the buy signal. See more of Medpace Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.